We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

News   Mar 19, 2018 | Original story from the Huntsman Cancer Institute (HCI)

 
Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

These are the HCI physicians from left to right: Paul Shami, M.D., Tibor Kovacsovics, M.D. and Michael Deininger, M.D., Ph.D. Credit: Jonathan Martinez, Huntsman Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

Probiotics May Help To Alleviate Depression

News

Probiotics either taken by themselves or when combined with prebiotics, may help to ease depression, suggests a new review, although further investigation is needed.

READ MORE

Common Genetic Variant Identified As Frequent Cause of Deafness

News

A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research.

READ MORE

Cell Therapeutic Reverses Age-related Impairments in Animal Model

News

Using an animal model, researchers have demonstrated that age-related frailty and immune decline can be halted and even partially reversed using a novel cell-based therapeutic approach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE